CNETS is committed to improving the quality of life and survival of NET patients across Canada and we have been supporting NET research since 2011, with independent competition management commencing in 2016.  Since this time CNETS has funded twenty-one (21) NET Cancer Research Grants through our national grant program.

CNETS is delighted to announce the expansion of our funding program to specifically fund projects arising from the collaboration between the commonwealth nations of Canada, Australia and New Zealand.

The exceptional collaboration among this group of NET professionals has inspired CNETS to support the incredible ideas and commitment of this group.

The inaugural CNETS Research Grant Competition, exclusively available to the CommNETs membership, will provide two grants up to a maximum of $15,000 per project.  CNETS has a particular interest in supporting projects focused on nutrition and diet but will consider other NET initiatives as well.

A huge thanks to all our donors and fundraisers who make it possible for CNETS to fund grants supporting NET research.



The eligible applications must include at least one applicant from each a Canadian and Australian or New Zealand hospital and/or research center that treats NET patients. The Nominated Principal Applicant must be an independent researcher with a clinical or an academic or research appointment at an eligible institution, such as a Government-recognized Canadian, Australian or New Zealand hospital, Institution or University where NET patients are treated or where there is active NET-related research program.


Relevance of the application to the focused area of Neuroendocrine Tumour (NET) research. CNETS has a particular interest in funding nutrition or diet-related initiatives however other applications are encouraged as well.

The eligible project must involve a clinical trial or a clinical or fundamental research project (including animal or cellular models) to examine issues relevant for the understanding of the origin and development of Neuroendocrine tumors (NETs), their diagnosis and treatment.

The onus is on the applicant to justify the request in terms of its relevance to the diagnosis and therapy for NET patients by these selected approaches.


The 2023 Neuroendocrine Tumour Research Grant competition is open specifically to CommNETs members, to provide grant-in-aid for two (2) projects up to a maximum of $15,000 per project.

We recognize that the grant-in-aid from CNETS may fund only part of the total cost of a project. Hence the applicants are strongly encouraged to leverage the CNETS grant to raise matching and more funds from other sources to conduct a strong project that has direct relevance to the theme of this grant cycle. For the projects with leveraged funding, the applicants must provide evidence of having secured or made plans to secure the remaining funds to successfully execute the entire project.

The project may be of maximum duration of two years and successful projects would remain eligible for renewal of funding in future competitions, subject to the availability of funds and relevant productivity from the previously funded project.

Once a grant has been offered, the Grantee has six (6) months to sign the Agreement; after which the grant offer will be withdrawn by CNETS. Fifteen Thousand Dollars ($15,000) will be paid upon signing the Agreement. A final report of the project is due to CNETS no later than 31st December 2025.


Any questions may be directed to: CNETS Phone: 416-628-3189 or 1-844-628-6788 or by Email at:


Call for Applications: November 1, 2023

Application Submission Deadline EXTENDED: February 28, 2024

Anticipated Notification of Decisions:  March 30, 2024

Funding Availability / Start Date: 2 years starting May 1, 2024

Share This Story, Choose Your Platform!